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Abstract  
In this article, an aramid of 4,4′-(1,3-phenylenedioxy)dianiline and terephthaloyl chloride was prepared. 
Afterwards, Nylon 6/6 and aramid were used to prepare sol-gel coated and non-coated blend fibers reinforced 
with nanodiamond (ND). In this way, four types of fibers were fabricated i.e. aramid/Nylon 6/6 fibers 
(Ar/N66) and aramid/Nylon 6/6/nanodiamond fibers (Ar/N66//ND) and sol-gel coated s-Ar/N66 and 
s-Ar/N66//ND fibers. The fibers were fabricated via Brabender single screw extruder at 200 °C. The Ar/N66 
and Ar/N66//ND fibers were coated by means of simple dip-coating technique. Fourier transform infrared 
spectroscopy was used for structural characterization. Scanning electron microscopic images of non-coated 
and sol-gel coated fibers were scanned for morphological comparison. Glass transition temperature of the sol 
gel s-Ar/N66 fibers increased up to 232 °C, while that of s-Ar/N66//ND was enhanced to 240 °C relative to 
neat fibers. Moreover, the sol-gel coated s-Ar/N66//ND (8.08%) fibers had higher water absorbing tendency 
than non-coated Ar/N66//ND (7.66 %). 
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Introduction 
Dengue fever (UK /ˈdɛŋɡeɪ/ or US /ˈdɛŋɡiː/), also called as breakbone fever, is a mosquito-borne tropical 
disease and the most common arthropod-borne viral (arboviral) illness in humans. Worldwide around 2.5-3 
billion people live in approximately 112 countries that experience dengue transmission. Estimates suggest that 
50 to 528 million people worldwide a year, causing around half a million hospitalizations [1], [2]. Dengue 
hemorrhagic fever (DHF) is an endemic disease in South East Asia including India [3-11]. Four serotypes of 
Dengue virus were documented till now which are DEN-1, DEN-2, DEN-3 and DEN-4 respectively [10, 11].  
Each year dengue hemorrhagic fever worldwide causes 22,000 deaths (mainly in children) [12, 13], [14]. In 
the last 50 years Dengue incidence increased 30 fold according to WHO [14]. Mean cost of illness from 
dengue was higher than other febrile illnesses [15] and has a disease burden estimated at 1,600 
disability-adjusted life years per million population [16], which is a matter of serious concern in developing 
countries [17].  Dengue fever is a self-limiting illness with a mortality rate of less than 1%. With adequate 
treatment, dengue hemorrhagic fever has a mortality rate of 2-5%. When left untreated, dengue hemorrhagic 
fever mortality rate reaches as high as 50%. The fatality rate of dengue shock syndrome varies by country 
ranging from 12-44%.  
Severe dengue (dengue hemorrhagic fever-DHF and dengue shock syndrome-DSS) causes serious 
complications due to plasma leak, fluid accumulation in body cavities, respiratory distress, severe bleeding, or 
organ dysfunction. Various common complications include encephalitis, myocarditis, acute motor weakness, 
Guillan–Barre like syndrome, acute liver failure, lupus erythematosus, hemophagocytic syndrome, acute 
kidney injury etc. [18]. Acute pancreatitis is a rare complication of Dengue and few cases were reported 
regarding new onset Diabetes in Dengue infection.  
Case report 
A 30 year-old man was bought to emergency room with breathlessness, generalized fatigue with gasping for 
breath. As GCS was 5/15 patient was intubated and mechanically ventilated in Intensive care unit. History 
from relatives revealed fever with chills since 6 days and shortness of breath from 2 days for which he was 
admitted in local clinic and was treated with prophylactic antibiotics. Patient was diagnosed with dengue fever 
as the NS1 antigen and dengue IgM antibody being positive. Patient’s platelet count dropped to 12000/ 
microliter and was given 1 single donor platelet concentrate transfusion. 
As the condition of the patient deteriorated, he was referred to our hospital.  Relatives denied illegal drug 
use or but informed presence of infected people with dengue in his village. His physical examination during 
admission was remarkable for fever (40°C), hypotension (BP: systolic 70 mm of hg), cyanosis and other signs 
of systemic inflammatory response syndrome (SIRS), including increased respiratory (38/min) and heart 
(136/min) rates. Systemic examination revealed dullness on bilateral infra scapular, interscapular, axillary and 
infra axillary areas. Bilateral basal crepitations were present.  
Chest radiography showed bilateral pleural effusion with alveolointerstitial infiltrate in left hemithorax. 
Patient was started on antibiotics Levofloxacin 750mg 24hourly in view of increased WBC count (25900/
mm
3
) and chest radiography features. 3 samples of Blood culture and endotracheal tube aspirate for influenza 
were sent.   
Investigations revealed total white blood cell count of 25,900 /mm3 (neutrophils 24%, lymphocytes 70%, 
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eosinophils 3%, monocytes 3%) ESR 50mm/hr.), hemoglobin of 10.3mg/dl, platelet count of 9000/microliter, 
red blood cell (RBC) of 42300/mL, hematocrit of 48.5 and mean corpuscular volume (MCV) of 90.1 fL. The 
arterial blood gases had pH of 7.32, a PO2 of 61 mmHg, PCO2 of 35.5mmHg and 17.2 mmol/l of bicarbonate. 
Renal function test was abnormal with creatinine of 2.6mg/dl and blood urea of 70mg/dl. Liver function test 
was normal except for mild elevation of SGOT and SGPT.ECG showed tachycardia and ST –T changes in lead 
3. Echocardiography was normal with ejection fraction of 60%. An ultrasound abdomen revealed bulky and 


























Figure 2 Ultrasound abdomen showing gallbladder wall thickening, fatty liver and ascites. 
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Figure 3 Ultrasound abdomen showing bulky and hypoechoic pancreas indicative of pancreatitis, fatty liver and 
ascites. 
Computerized tomography of abdomen revealed diffusely enlarged pancreas with scattered non enhancing 
areas suggestive of necrosis, extensive peripancreatic fat stranding, moderate ascites and bilateral pleural 
effusion [Figures 4-8].Investigations revealed hyperlipasemia and hypocalcaemia with serum amylase of 
2350.0 U/L (normal range 30-110 U/L); serum lipase of 975.0 UI/L (normal range 23.0-300.0 UI/L) and 
calcium 6.16 mg/dL (normal range 8.4-10.2 mg/dL). Investigations done 4 days ago in a local clinic including 
Fasting and post prandial blood sugars, lipid profile were normal.  
On admission random blood sugar was 200mg/dl. 4
th
 hourly GRBS was persistently high above 200mg/dl. 
Glycosylated hemoglobin was 5.1. Patient was diagnosed as severe dengue hemorrhagic fever with acute 
pancreatitis, new onset diabetes Mellitus, acute kidney injury, and decompensated shock. Mechanical 
ventilation was continued with PEEP of 8cm of H20. Intravenous fluids 0.9% NS at 20 mL/kg/h initially and 
then infusion of 10 mL/kg/h was given. Condition of patient deteriorated on 2nd day with oliguria, shock and 
multiple organ dysfunction syndrome (MODS). Patient required blood transfusion, inotropic support 
(Dopamine at 15 μg/min) and crystalloids. Patient was given 2 packed RBC transfusion, 2 single donor 
platelets and fresh frozen plasma.  
Condition of patient improved progressively with improvement of blood pressure, no bleeding 
manifestations and radiography revealing reduction in pulmonary infiltrates. Patient was extubated on day 6 
with continuation of antibiotics. All blood cultures as well as serological tests including HIV were negative. 
On day 8 WBC count was 9600/mm3, Platelet count was 149,000/microliter and hemoglobin was 10.4g/dl. But, 
patient continued to have high blood sugars and was advised insulin to be continued. On day 10 patient was 
discharged after repeat Ultrasound abdomen showing reduction of pancreatitis and ascites. 
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Figure 4 Diffusely enlarged pancreas with scattered non enhancing areas suggestive of necrosis, extensive 










Figure 5 Diffusely enlarged pancreas with scattered non enhancing areas suggestive of necrosis, extensive 
peripancreatic fat stranding, moderate ascites and bilateral pleural effusion 
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Figure 6 Diffusely enlarged pancreas with scattered non enhancing areas suggestive of necrosis, extensive 











Figure 7 Diffusely enlarged pancreas with scattered non enhancing areas suggestive of necrosis, extensive 
peripancreatic fat stranding, moderate ascites and bilateral pleural effusion 
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Figure 8 Diffusely enlarged pancreas with scattered non enhancing areas suggestive of necrosis, extensive 








Figure 9 WHO classification of Dengue 
Discussion 
Infection with one dengue serotype results in lifelong homotypic immunity and a very brief period of partial 
heterotypic immunity, but an individual can be infected by all 4 serotypes separately. Dengue is transmitted by 
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the bite of an infected Aedes (subgenus Stegomyia) mosquito [19]. Female Aedes mosquitoes feed during 
daytime inflicting an innocuous bite, on the back of the neck and the ankles usually. They are easily disturbed 
during a blood meal, and they move on to another individual, making them efficient vectors. Entire family 
members can develop infection within a 24- to 36-hour period, due to a single infected mosquito. Transmission 
occurs after 8-12 days of viral replication in the salivary glands of mosquito (extrinsic incubation period). Life 
span of A aegypti ranges from 15 to 65 days.  
Incubation period of Dengue is 3-14 days (average 4-7 days) and viral replication occurs in target dendritic 
cells. Infection of target cells in reticuloendothelial system, such as dendritic cells, hepatocytes, and 
endothelial cells occur [20-23]. WHO (2009) classification of Dengue is illustrated in Figure 9. The four 
cardinal features of dengue hemorrhagic fever are increased vascular permeability, fever, hemorrhage, and 
marked thrombocytopenia (100,000 cells/mm3 or lower). Dengue shock syndrome (DSS) is usually 
characterized by a rapid, weak pulse with narrowing of the pulse pressure (<20 mmHg (2.7 kPa), regardless of 
pressure levels, e.g. 100/90 mmHg (13.3/12.0 kPa)) or hypotension with cold, clammy skin and restlessness.  
The acute surgical complications of dengue fever are acute appendicitis, acute pancreatitis, acute acalculous 
cholecystitis and nonspecific peritonitis. Other atypical presentations described are neurological 
(encephalopathy, seizures, acute motor weakness, neuritis, Guillane-Barre syndrome, acute viral myositis, 
hypokalemic paralysis, and acute encephalitis); hepatic (acute hepatic failure, hepatomegaly, coagulation 
disturbances); cardiac (myocarditis, sinoatrial block, atrio-ventricular dissociation); acute kidney injury, 
systemic lupus erythematosus, Kawasaki disease, uveitis, acute inflammatory colitis, hemophagocytic 
syndrome etc.  
Our patient met the WHO criteria (2012) of case definition of severe dengue [24]. Acute pancreatitis 
diagnosis was based on clinical features, history of epigastric pain, fever, abdominal tenderness, enlargement 
of the pancreas on ultrasound examination and CT abdomen with normal hepatobiliary function, increased 
serum amylase and lipase 3 times above normal. One series regarding DHF outbreak in Taiwan (2002) 
reported pancreatitis (defined by a lipase level 3-fold greater) in three patients with acute DHF and few other 
reports from other asian countries [25]. Acute pancreatitis causing Diabetes mellitus is a very rare 
manifestation of dengue [26-29]. 
The cause for dengue fever presenting with acute abdomen is unclear. Pancreatic histology reports are not 
available to prove direct viral invasion. The exact mechanism of pancreatitis is not clear and was thought to be 
multifactorial. Several hypotheses were proposed based on other viral pancreatitis research. They include 
direct inflammation, destruction of pancreatic acinar cells; autoimmune response to pancreatic islet cells with 
viral infection as a trigger, similarity between viral and islet cells antigens inducing autoimmune response, 
edema of the ampulla of Vater causing obstruction to the outflow of pancreatic fluid.  
Conclusion 
Very few cases were reported dengue causing pancreatitis and permanent insulin requiring diabetes. This 
complication is underreported and lack of awareness may prove fatal to a patient in Dengue shock syndrome 
(DSS). Even though pancreatitis treatment doesn’t differ from other causes, more chances of bleeding and 
increased capillary permeability causing third space loss should be addressed more aggressively.  
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